Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2021 Apr;38(5):469-476.
doi: 10.1055/s-0039-1698457. Epub 2019 Oct 10.

Neonatal Antiepileptic Medication Treatment Patterns: A Decade of Change

Affiliations
Comparative Study

Neonatal Antiepileptic Medication Treatment Patterns: A Decade of Change

Vi T Le et al. Am J Perinatol. 2021 Apr.

Abstract

Objective: This study aims to describe the frequency and characteristics of anticonvulsant medication treatments initiated in the neonatal period.

Study design: We analyzed a cohort of neonates with a seizure diagnosis who were discharged from institutions in the Pediatric Health Information System between 2007 and 2016. Adjusted risk ratios and 95% confidence intervals for characteristics associated with neonatal (≤ 28 days postnatal) anticonvulsant initiation were calculated via modified Poisson regression.

Results: A total of 6,245 infants from 47 institutions were included. There was a decrease in both phenobarbital initiation within the neonatal period (96.9 to 91.3%, p = 0.015) and continuation at discharge (90.6 to 68.6%, p <0.001). Levetiracetam (7.9 to 39.6%, p < 0.001) initiation within the neonatal period and continuation at discharge (9.4 to 49.8%, p < 0.001) increased. Neonates born at ≥ 37 weeks' gestation and those diagnosed with intraventricular hemorrhage, ischemic/thrombotic stroke, other hemorrhagic stroke, and hypoxic ischemic encephalopathy (HIE) had a higher probability of anticonvulsant administration. The most prevalent diagnosis was HIE (n = 2,223, 44.4%).

Conclusion: Phenobarbital remains the most widely used neonatal seizure treatment. Levetiracetam is increasingly used as a second line therapy. Increasing levetiracetam use indicates a need for additional study to determine its effectiveness in reducing seizure burden and improving long-term outcomes.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1.
Figure 1.
Antiepileptic medication utilization by discharge year.
Figure 2.
Figure 2.
Percent of infants receiving phenobarbital, fosphenytoin sodium/phenytoin, and levetiractam during the neonatal period by discharge year.
Figure 3.
Figure 3.
Variation of phenobarbital, fosphenytoin sodium/phenytoin, and levetiractam receipt among all hospitalized infants per service day.
Figure 4.
Figure 4.
First-line antiepileptic variation over time.
Figure 5.
Figure 5.
Reporting of HIE Severity per year among infants receiving hypothermia treatment

References

    1. Glass HC, Shellhaas RA, Wusthoff CJ, et al. Contemporary Profile of Seizures in Neonates: A Prospective Cohort Study. The Journal Of Pediatrics. 2016;174:98–103.e1. doi:10.1016/j.jpeds.2016.03.035 - DOI - PMC - PubMed
    1. Uria-Avellanal C, Marlow N, Rennie JM. Outcome following neonatal seizures. Seminars In Fetal & Neonatal Medicine. 2013;18(4):224–232. doi:10.1016/j.siny.2013.01.002 - DOI - PubMed
    1. Booth D, Evans DJ. Anticonvulsants for neonates with seizures. The Cochrane Database Of Systematic Reviews. 2004;(4):CD004218. - PubMed
    1. Blume HK, Garrison MM, Christakis DA. Neonatal seizures: Treatment and treatment variability in 31 United States pediatric hospitals. Journal of Child Neurology. 2009;24(2):148–154. doi:10.1177/0883073808321056 - DOI - PubMed
    1. Ahmad KA, Desai SJ, Bennett MM, et al. Changing antiepileptic drug use for seizures in US neonatal intensive care units from 2005 to 2014. Journal of Perinatology. 2017;37(3):296–300. doi:10.1038/jp.2016.206 - DOI - PubMed

Publication types